Search

everythinglearnresearchcommunity

for

Search:↓

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

Surgery is the main treatment for liver hydatidosis, but has risks; albendazole is the most effective drug but can have side effects.

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Understanding how fetal wounds heal could help improve healing in adults.

Baricitinib is effective and safe for treating severe alopecia areata.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Oral medication is necessary to treat scalp fungus in children, with griseofulvin being the usual choice.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Many skin patients also have mental health issues, and doctors should treat both together.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.